✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Product QualityDosingCannabinoidsTerpenesStandardization Why This MattersAdvanced cannabis breeding techniques are creating more consistent cannabinoid and...
Weed Potency Is Skyrocketing: Should We Worry? – YouTube
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DosingThcPatient SafetyProduct QualityAdverse Effects Why This MattersRising THC concentrations in commercial cannabis products directly...
A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care
WHY IT MATTERS: Patients using medical cannabis may soon have access to digital tools that help their physicians track symptom changes and adjust treatment more precisely over time. CLINICAL OVERVIEW: The integration of prescription digital therapeutics into cannabinoid medicine represents a meaningful step toward structuring clinical care around measurable outcomes, individualized dosing protocols, and accountable therapeutic frameworks. Digital tools have the potential to capture real-world patient data that traditional clinical encounters often miss, including symptom trajectories, titration responses, and adherence patterns.
Nebraska’s Medical Cannabis Commission holds hearing on emergency regulations – KETV
WHY IT MATTERS: If Nebraska’s 5-gram THC cap becomes permanent, patients with serious medical conditions may find that legally obtained cannabis falls far short of the amounts needed for meaningful symptom management, effectively rationing medicine by regulation rather than clinical need. CLINICAL OVERVIEW: Nebraska’s newly formed medical cannabis commission is establishing emergency regulations that include a strict 90-day THC possession cap of 5 grams for patients, which falls dramatically below dosing thresholds considered therapeutically meaningful for most qualifying conditions. Clinically, patients managing chronic pain, neurological disorders, or cancer-related symptoms often require significantly higher amounts to achieve consistent symptom relief, making such a low ceiling a practical barrier to effective care.
Cannabis Use Associated with Worse Working Memory – EMJ
New research links heavy cannabis use to reduced brain activation during memory tasks. Here’s what you need to know: The study focused on heavy use patterns, not structured medical dosing Dose, frequency, and cannabinoid profile all matter for cognitive outcomes Working memory changes may be more pronounced with high-THC, high-frequency use ️ Medical patients using low-to-moderate doses under guidance face a different risk profile This is why we monitor cognitive function and adjust protocols over time The takeaway? Cannabis isn’t one-size-fits-all, and neither is the research. Talk to your cannabis clinician about what this means for YOUR care. Heavy cannabis use may impair working memory, but dose and context matter enormously. Medical patients deserve nuance, not headlines.